Insights

Helsinn Group and Chugai Pharma Marketing Enter Into Agreement for Marketing Rights of Netupitant-Palonosetron Fixed-Dose Combination (NEPA)

Under the exclusive agreement, Chugai Pharma Marketing gains rights for the marketing of palonosetron in the UK and NEPA in the UK and in...

BioSpain 2014 Expands its Investment Forum Through Wider Range of Investor Profiles and more Participating Companies

Insights

Biospain 2014 is currently seeking and selecting projects for presentation as part of its Investment Forum, one of the most high profile in the...

Galena Biopharma Acquires Mills Pharmaceuticals

Insights

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it...

Subscribe Our Newsletter

White Papers

Whitepapers

The Future of Digital Health

Whitepapers 21st February 2018 0

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

Whitepapers 19th November 2015 0

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Whitepapers 19th November 2015 0

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

Insights

About us

Resources

Advertise

Subscribe